Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:49 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1 / Phase 2TerminatedINTERVENTIONAL

RCT for Women With a Persisting Pregnancy of Unknown Location

ClinicalTrials.gov · NCT01800162 · Registry updated: 2017-12-29

Condition / research focus: Persistent Pregnancy of Unknown Location; Ectopic Pregnancy
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2013-02. Completion: 2013-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Methotrexate (drug)
Uterine Evacuation (procedure)
Expectant Management (other)

Where the study takes place — 2 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Greenville Hospital System University Medical Center
Greenville, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)

ClinicalTrials.gov · NCT03307720 · Registry updated: 2017-12-11

Condition / research focus: Ovulation Induction; In Vitro Fertilization (IVF); Infertility, Female; Oocytes
Sponsor: Ginegorama S.L.
Countries with listed sites: Spain
Registry dates and results: Start: 2017-12-18. Completion: 2018-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropin Releasing Hormone Agonists (GNRH-A) (drug) — also listed as: Agonist trigger
Human chorionic gonadotropin (drug) — also listed as: HCG trigger

Where the study takes place — 1 listed sites

Reproduccion Bilbao Assisted Reproduction Center
Bilbao, Bizkaia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

ClinicalTrials.gov · NCT01687712 · Registry updated: 2017-12-05

Condition / research focus: Infertility
Sponsor: Fertility Biotech AG
Countries with listed sites: United States
Registry dates and results: Start: 2013-11-25. Completion: 2016-11-14 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

AFOLIA (drug) — also listed as: Follitropin-alfa
Gonal-f® RFF (drug) — also listed as: Follitropin-alfa

Where the study takes place — 22 listed sites

Physicians Research Group
Tempe, Arizona, United States
Site recruitment: Not reported
HRC Fertility
Encino, California, United States
Site recruitment: Not reported
Reproductive Associates of Delaware
Newark, Delaware, United States
Site recruitment: Not reported
FL Fertility Institution
Tampa, Florida, United States
Site recruitment: Not reported
Georgia Reproductive Specialists
Atlanta, Georgia, United States
Site recruitment: Not reported
Fertility Centers of Illinois
Chicago, Illinois, United States
Site recruitment: Not reported
In Via Fertility Specialists
Hoffman Estate, Illinois, United States
Site recruitment: Not reported
Shady Grove Fertility RSC
Rockville, Maryland, United States
Site recruitment: Not reported
Nevada Center for Reproductive Medicine
Reno, Nevada, United States
Site recruitment: Not reported
Cooper Institute of Reproductive Hormonal Disorders, P.C.
Marlton, New Jersey, United States
Site recruitment: Not reported
Institute for Reproductive Health
Cincinnati, Ohio, United States
Site recruitment: Not reported
Abington Reproductive Medicine
Abington, Pennsylvania, United States
Site recruitment: Not reported
Main Line Fertility Center
Bryn Mawr, Pennsylvania, United States
Site recruitment: Not reported
Shady Grove Fertility RSC, Chesterbrook, PA
Chesterbrook, Pennsylvania, United States
Site recruitment: Not reported
University of Penn
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Fertility Associates of Memphis
Memphis, Tennessee, United States
Site recruitment: Not reported
Texas Fertility Center
Austin, Texas, United States
Site recruitment: Not reported
Center for Assisted Reproduction
Bedford, Texas, United States
Site recruitment: Not reported
Fertility Specialists of Houston
Houston, Texas, United States
Site recruitment: Not reported
Houston Fertility Institute
Houston, Texas, United States
Site recruitment: Not reported
Center of Reproducitve Medicine
Webster, Texas, United States
Site recruitment: Not reported
Jones Institute for Reproductive Medicine
Norfolk, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Timing of Initiation of LMWH Administration in Pregnant Women With APS

ClinicalTrials.gov · NCT02326051 · Registry updated: 2017-11-29

Condition / research focus: Recurrent Miscarriage; Antiphospholipid Syndrome
Sponsor: Mohamed Sayed Abdelhafez
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-12. Completion: 2017-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Enoxaparin (drug) — also listed as: Clexan
Enoxaparin (drug) — also listed as: Clexan

Where the study takes place — 2 listed sites

Obstetrics and Gynecology Department in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported
Private practice settings
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Long Protocol and Growth Hormone in Poor Responders

ClinicalTrials.gov · NCT02338206 · Registry updated: 2017-11-29

Condition / research focus: Infertility
Sponsor: Woman's Health University Hospital, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-03. Completion: 2017-11-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Growth hormone (drug) — also listed as: Norditropin, Novo nordisk

Where the study takes place — 1 listed sites

Kasr el aini hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa for Ovarian Stimulation in Donors

ClinicalTrials.gov · NCT03354494 · Registry updated: 2017-11-28

Condition / research focus: Controlled Ovaria Stimulation
Sponsor: Fundacion Dexeus
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-01. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3UnknownINTERVENTIONAL

Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?

ClinicalTrials.gov · NCT03353883 · Registry updated: 2017-11-27

Condition / research focus: Infertility, Female
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-06-01. Completion: 2018-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin SR (drug) — also listed as: Decapeptyl

Where the study takes place — 1 listed sites

Benha university hospital
Banhā, Qaluibia, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Prediction of Preterm Labor in Asymptomatic High Risk Women

ClinicalTrials.gov · NCT03334877 · Registry updated: 2017-11-08

Condition / research focus: Preterm Labor
Sponsor: Zagazig University
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-05-15. Completion: 2017-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

β -human chorionic gonadotropin (diagnostic_test)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

ClinicalTrials.gov · NCT03118830 · Registry updated: 2017-11-07

Condition / research focus: Invitro Fertilization
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-04-21. Completion: 2017-11-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin (drug) — also listed as: Decapeptyl
cetrorelix (drug) — also listed as: Cetrotide
Recombinant Follicle Stimulating Hormone (drug) — also listed as: Gonal-f

Where the study takes place — 1 listed sites

Ahmed Maged
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Simplifying First Trimester Medical Abortion Follow-up

ClinicalTrials.gov · NCT03014193 · Registry updated: 2017-11-06

Condition / research focus: Medical Abortion
Sponsor: Gynuity Health Projects
Countries with listed sites: Armenia · Georgia · Kazakhstan
Registry dates and results: Start: 2017-01. Completion: 2017-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semiquantitative Multi-Level Pregnancy Test (device)

Where the study takes place — 5 listed sites

Gyumri Maternity Hospital
Gyumri, Armenia
Site recruitment: Not reported
Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology
Yerevan, Armenia
Site recruitment: Not reported
Batumi International Hospital
Batumi, Georgia
Site recruitment: Not reported
David Gagua Clinic
Tbilisi, Georgia
Site recruitment: Not reported
City Policlinic #17
Almaty, Kazakhstan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis

ClinicalTrials.gov · NCT02099214 · Registry updated: 2017-10-20

Condition / research focus: Myocardial Iron Overload; HFE-Associated Hereditary Hemochromatosis
Sponsor: Rennes University Hospital
Countries with listed sites: France
Registry dates and results: Start: 2014-11-05. Completion: 2017-10-18 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

3Tesla cardiac MRI (device)
Electrocardiogram (EKG) (device)
Iron and cardiac markers (biological)
Pregnancy test (biological)
Echocardiography at rest (device)
Urinary pregnancy test (biological)
3Tesla abdominal MRI (device)

Where the study takes place — 1 listed sites

Rennes University Hospital
Rennes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effects of Clomiphene Citrate Ovulation Induction on Frozen Embryo Transfer

ClinicalTrials.gov · NCT03309436 · Registry updated: 2017-10-13

Condition / research focus: Infertility, Female; Clomiphene Citrate
Sponsor: ShangHai Ji Ai Genetics & IVF Institute
Countries with listed sites: China
Registry dates and results: Start: 2017-08-07. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphene Citrate protocol (drug) — also listed as: CC
Procedure (procedure) — also listed as: GnRH antagonist protocol

Where the study takes place — 1 listed sites

Shanghai Jiai Genetics & IVF Institute
Shanghai, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Adiposity and Airway Inflammation in HIV-Associated Airway Disease

ClinicalTrials.gov · NCT02975258 · Registry updated: 2017-10-13

Condition / research focus: Asthma; HIV; Adiposity
Sponsor: University of Pittsburgh
Countries with listed sites: United States
Registry dates and results: Start: 2015-09. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (8)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood draw (procedure)
Questionnaires (other)
Spirometry (procedure) — also listed as: Lung function testing
Methacholine challenge test (procedure) — also listed as: Asthma Test
Quantitative CT scans (radiation) — also listed as: CT scan of the chest, CT scan of the abdomen
Urine pregnancy test (procedure)
Adipose biopsy (procedure) — also listed as: Fat pad biopsy, Fat biopsy
Exhaled nitric oxide measurement (procedure) — also listed as: ENO measurement

Where the study takes place — 1 listed sites

University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Improved Medically Assisted Procreation Monitoring

ClinicalTrials.gov · NCT03274765 · Registry updated: 2017-09-07

Condition / research focus: Infertility
Sponsor: Rennes University Hospital
Countries with listed sites: France
Registry dates and results: Start: 2017-11-15. Completion: 2018-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dosage of oestradiol (diagnostic_test)

Where the study takes place — 1 listed sites

Rennes University Hospital
Rennes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI

ClinicalTrials.gov · NCT02741154 · Registry updated: 2017-09-06

Condition / research focus: Infertility Indicated for ICSI
Sponsor: Minia University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-08-12. Completion: 2017-09-03 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

induction with aromataze inhibitor (drug) — also listed as: letrozole
HMG (drug) — also listed as: merional
GnRh a (drug) — also listed as: decapeptyl
HCG (drug) — also listed as: choriomon

Where the study takes place — 1 listed sites

Minia University
Minya, Minya Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

ClinicalTrials.gov · NCT01638026 · Registry updated: 2017-08-29

Condition / research focus: Infertility
Sponsor: HaEmek Medical Center, Israel
Countries with listed sites: Israel
Registry dates and results: Start: 2012-09. Completion: 2017-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TRIPTORELIN ACETATE, hCG (drug)

Where the study takes place — 1 listed sites

Hemek medical centre
Afula, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)

ClinicalTrials.gov · NCT02047227 · Registry updated: 2017-08-24

Condition / research focus: Infertility
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Germany
Registry dates and results: Start: 2014-01-31. Completion: 2015-08-31 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pergoveris® (drug) — also listed as: r-hFSH/r-hLH, Follitropin alfa/Lutropin alfa
GONAL-f® (drug) — also listed as: r-hFSH, Follitropin alfa
Recombinant human chorionic gonadotrophin (r-hCG) (drug) — also listed as: Ovidrel®, Ovitrelle®, choriogonadotropin alfa

Where the study takes place — 1 listed sites

Please contact the Merck KGaA Communication Center
Darmstadt, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients

ClinicalTrials.gov · NCT02466204 · Registry updated: 2017-08-22

Condition / research focus: Infertility
Sponsor: Vietnam National University
Countries with listed sites: Vietnam
Registry dates and results: Start: 2015-06-01. Completion: 2017-08-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

corifollitropin alfa (drug) — also listed as: Elonva
Follitropin Beta (drug) — also listed as: Puregon

Where the study takes place — 2 listed sites

My Duc Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported
Research Center for Genetics and Reproductive Health
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cabergoline and Coasting to Prevent OHSS

ClinicalTrials.gov · NCT01984320 · Registry updated: 2017-08-14

Condition / research focus: OHSS
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-10. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ICSI (procedure)

Where the study takes place — 1 listed sites

IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini)
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

ClinicalTrials.gov · NCT01042704 · Registry updated: 2017-07-31

Condition / research focus: Myeloma
Sponsor: Robert Redner, MD
Countries with listed sites: United States
Registry dates and results: Start: 2008-02. Completion: 2015-03 (may be estimated). No results posted in this registry response.

Products and interventions (10)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bendamustine (drug)
Lenalidomide (drug)
Dexamethasone (drug)
Aspirin (drug)
Prophylaxis (drug)
Antibiotic (drug)
Biweekly Follow Up (other)
Cyclical Follow Up (other)
Restaging (other)
Post-Treatment Follow Up (other)

Where the study takes place — 22 listed sites

Karmanos Cancer Institute
Detroit, Michigan, United States
Site recruitment: Not reported
UPMC Cancer Centers - Teramana Cancer Center
Steubenville, Ohio, United States
Site recruitment: Not reported
UPMC Cancer Centers - Beaver
Beaver, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Jefferson
Clairton, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Arnold Palmer at Mountain View
Greensburg, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Arnold Palmer at Oakbrook
Greensburg, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Indiana
Indiana, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Johnstown
Johnstown, Pennsylvania, United States
Site recruitment: Not reported
Hematology-Oncology Associates of UPCI
McKeesport, Pennsylvania, United States
Site recruitment: Not reported
Hematology/Oncology - Private Practice
McKeesport, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Monroeville
Monroeville, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Arnold Palmer at Mt. Pleasant
Mount Pleasant, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - New Castle
New Castle, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - St. Margaret's
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Passavant
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
VA Healthcare System - 646
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Drake
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Uniontown
Uniontown, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Washington
Washington, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - North Hills
Wexford, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Windber
Windber, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:49 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1 / Phase 2TerminatedINTERVENTIONAL

RCT for Women With a Persisting Pregnancy of Unknown Location

ClinicalTrials.gov · NCT01800162 · Registry updated: 2017-12-29

Condition / research focus: Persistent Pregnancy of Unknown Location; Ectopic Pregnancy
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2013-02. Completion: 2013-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Methotrexate (drug)
Uterine Evacuation (procedure)
Expectant Management (other)

Where the study takes place — 2 listed sites

University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Greenville Hospital System University Medical Center
Greenville, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)

ClinicalTrials.gov · NCT03307720 · Registry updated: 2017-12-11

Condition / research focus: Ovulation Induction; In Vitro Fertilization (IVF); Infertility, Female; Oocytes
Sponsor: Ginegorama S.L.
Countries with listed sites: Spain
Registry dates and results: Start: 2017-12-18. Completion: 2018-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropin Releasing Hormone Agonists (GNRH-A) (drug) — also listed as: Agonist trigger
Human chorionic gonadotropin (drug) — also listed as: HCG trigger

Where the study takes place — 1 listed sites

Reproduccion Bilbao Assisted Reproduction Center
Bilbao, Bizkaia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

ClinicalTrials.gov · NCT01687712 · Registry updated: 2017-12-05

Condition / research focus: Infertility
Sponsor: Fertility Biotech AG
Countries with listed sites: United States
Registry dates and results: Start: 2013-11-25. Completion: 2016-11-14 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

AFOLIA (drug) — also listed as: Follitropin-alfa
Gonal-f® RFF (drug) — also listed as: Follitropin-alfa

Where the study takes place — 22 listed sites

Physicians Research Group
Tempe, Arizona, United States
Site recruitment: Not reported
HRC Fertility
Encino, California, United States
Site recruitment: Not reported
Reproductive Associates of Delaware
Newark, Delaware, United States
Site recruitment: Not reported
FL Fertility Institution
Tampa, Florida, United States
Site recruitment: Not reported
Georgia Reproductive Specialists
Atlanta, Georgia, United States
Site recruitment: Not reported
Fertility Centers of Illinois
Chicago, Illinois, United States
Site recruitment: Not reported
In Via Fertility Specialists
Hoffman Estate, Illinois, United States
Site recruitment: Not reported
Shady Grove Fertility RSC
Rockville, Maryland, United States
Site recruitment: Not reported
Nevada Center for Reproductive Medicine
Reno, Nevada, United States
Site recruitment: Not reported
Cooper Institute of Reproductive Hormonal Disorders, P.C.
Marlton, New Jersey, United States
Site recruitment: Not reported
Institute for Reproductive Health
Cincinnati, Ohio, United States
Site recruitment: Not reported
Abington Reproductive Medicine
Abington, Pennsylvania, United States
Site recruitment: Not reported
Main Line Fertility Center
Bryn Mawr, Pennsylvania, United States
Site recruitment: Not reported
Shady Grove Fertility RSC, Chesterbrook, PA
Chesterbrook, Pennsylvania, United States
Site recruitment: Not reported
University of Penn
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Fertility Associates of Memphis
Memphis, Tennessee, United States
Site recruitment: Not reported
Texas Fertility Center
Austin, Texas, United States
Site recruitment: Not reported
Center for Assisted Reproduction
Bedford, Texas, United States
Site recruitment: Not reported
Fertility Specialists of Houston
Houston, Texas, United States
Site recruitment: Not reported
Houston Fertility Institute
Houston, Texas, United States
Site recruitment: Not reported
Center of Reproducitve Medicine
Webster, Texas, United States
Site recruitment: Not reported
Jones Institute for Reproductive Medicine
Norfolk, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Timing of Initiation of LMWH Administration in Pregnant Women With APS

ClinicalTrials.gov · NCT02326051 · Registry updated: 2017-11-29

Condition / research focus: Recurrent Miscarriage; Antiphospholipid Syndrome
Sponsor: Mohamed Sayed Abdelhafez
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-12. Completion: 2017-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Enoxaparin (drug) — also listed as: Clexan
Enoxaparin (drug) — also listed as: Clexan

Where the study takes place — 2 listed sites

Obstetrics and Gynecology Department in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported
Private practice settings
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Long Protocol and Growth Hormone in Poor Responders

ClinicalTrials.gov · NCT02338206 · Registry updated: 2017-11-29

Condition / research focus: Infertility
Sponsor: Woman's Health University Hospital, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-03. Completion: 2017-11-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Growth hormone (drug) — also listed as: Norditropin, Novo nordisk

Where the study takes place — 1 listed sites

Kasr el aini hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa for Ovarian Stimulation in Donors

ClinicalTrials.gov · NCT03354494 · Registry updated: 2017-11-28

Condition / research focus: Controlled Ovaria Stimulation
Sponsor: Fundacion Dexeus
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-01. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3UnknownINTERVENTIONAL

Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?

ClinicalTrials.gov · NCT03353883 · Registry updated: 2017-11-27

Condition / research focus: Infertility, Female
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-06-01. Completion: 2018-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin SR (drug) — also listed as: Decapeptyl

Where the study takes place — 1 listed sites

Benha university hospital
Banhā, Qaluibia, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Prediction of Preterm Labor in Asymptomatic High Risk Women

ClinicalTrials.gov · NCT03334877 · Registry updated: 2017-11-08

Condition / research focus: Preterm Labor
Sponsor: Zagazig University
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-05-15. Completion: 2017-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

β -human chorionic gonadotropin (diagnostic_test)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

ClinicalTrials.gov · NCT03118830 · Registry updated: 2017-11-07

Condition / research focus: Invitro Fertilization
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2017-04-21. Completion: 2017-11-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin (drug) — also listed as: Decapeptyl
cetrorelix (drug) — also listed as: Cetrotide
Recombinant Follicle Stimulating Hormone (drug) — also listed as: Gonal-f

Where the study takes place — 1 listed sites

Ahmed Maged
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Simplifying First Trimester Medical Abortion Follow-up

ClinicalTrials.gov · NCT03014193 · Registry updated: 2017-11-06

Condition / research focus: Medical Abortion
Sponsor: Gynuity Health Projects
Countries with listed sites: Armenia · Georgia · Kazakhstan
Registry dates and results: Start: 2017-01. Completion: 2017-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semiquantitative Multi-Level Pregnancy Test (device)

Where the study takes place — 5 listed sites

Gyumri Maternity Hospital
Gyumri, Armenia
Site recruitment: Not reported
Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology
Yerevan, Armenia
Site recruitment: Not reported
Batumi International Hospital
Batumi, Georgia
Site recruitment: Not reported
David Gagua Clinic
Tbilisi, Georgia
Site recruitment: Not reported
City Policlinic #17
Almaty, Kazakhstan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis

ClinicalTrials.gov · NCT02099214 · Registry updated: 2017-10-20

Condition / research focus: Myocardial Iron Overload; HFE-Associated Hereditary Hemochromatosis
Sponsor: Rennes University Hospital
Countries with listed sites: France
Registry dates and results: Start: 2014-11-05. Completion: 2017-10-18 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

3Tesla cardiac MRI (device)
Electrocardiogram (EKG) (device)
Iron and cardiac markers (biological)
Pregnancy test (biological)
Echocardiography at rest (device)
Urinary pregnancy test (biological)
3Tesla abdominal MRI (device)

Where the study takes place — 1 listed sites

Rennes University Hospital
Rennes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effects of Clomiphene Citrate Ovulation Induction on Frozen Embryo Transfer

ClinicalTrials.gov · NCT03309436 · Registry updated: 2017-10-13

Condition / research focus: Infertility, Female; Clomiphene Citrate
Sponsor: ShangHai Ji Ai Genetics & IVF Institute
Countries with listed sites: China
Registry dates and results: Start: 2017-08-07. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Clomiphene Citrate protocol (drug) — also listed as: CC
Procedure (procedure) — also listed as: GnRH antagonist protocol

Where the study takes place — 1 listed sites

Shanghai Jiai Genetics & IVF Institute
Shanghai, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Adiposity and Airway Inflammation in HIV-Associated Airway Disease

ClinicalTrials.gov · NCT02975258 · Registry updated: 2017-10-13

Condition / research focus: Asthma; HIV; Adiposity
Sponsor: University of Pittsburgh
Countries with listed sites: United States
Registry dates and results: Start: 2015-09. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (8)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood draw (procedure)
Questionnaires (other)
Spirometry (procedure) — also listed as: Lung function testing
Methacholine challenge test (procedure) — also listed as: Asthma Test
Quantitative CT scans (radiation) — also listed as: CT scan of the chest, CT scan of the abdomen
Urine pregnancy test (procedure)
Adipose biopsy (procedure) — also listed as: Fat pad biopsy, Fat biopsy
Exhaled nitric oxide measurement (procedure) — also listed as: ENO measurement

Where the study takes place — 1 listed sites

University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Improved Medically Assisted Procreation Monitoring

ClinicalTrials.gov · NCT03274765 · Registry updated: 2017-09-07

Condition / research focus: Infertility
Sponsor: Rennes University Hospital
Countries with listed sites: France
Registry dates and results: Start: 2017-11-15. Completion: 2018-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dosage of oestradiol (diagnostic_test)

Where the study takes place — 1 listed sites

Rennes University Hospital
Rennes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI

ClinicalTrials.gov · NCT02741154 · Registry updated: 2017-09-06

Condition / research focus: Infertility Indicated for ICSI
Sponsor: Minia University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-08-12. Completion: 2017-09-03 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

induction with aromataze inhibitor (drug) — also listed as: letrozole
HMG (drug) — also listed as: merional
GnRh a (drug) — also listed as: decapeptyl
HCG (drug) — also listed as: choriomon

Where the study takes place — 1 listed sites

Minia University
Minya, Minya Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

ClinicalTrials.gov · NCT01638026 · Registry updated: 2017-08-29

Condition / research focus: Infertility
Sponsor: HaEmek Medical Center, Israel
Countries with listed sites: Israel
Registry dates and results: Start: 2012-09. Completion: 2017-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

TRIPTORELIN ACETATE, hCG (drug)

Where the study takes place — 1 listed sites

Hemek medical centre
Afula, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)

ClinicalTrials.gov · NCT02047227 · Registry updated: 2017-08-24

Condition / research focus: Infertility
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Germany
Registry dates and results: Start: 2014-01-31. Completion: 2015-08-31 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pergoveris® (drug) — also listed as: r-hFSH/r-hLH, Follitropin alfa/Lutropin alfa
GONAL-f® (drug) — also listed as: r-hFSH, Follitropin alfa
Recombinant human chorionic gonadotrophin (r-hCG) (drug) — also listed as: Ovidrel®, Ovitrelle®, choriogonadotropin alfa

Where the study takes place — 1 listed sites

Please contact the Merck KGaA Communication Center
Darmstadt, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients

ClinicalTrials.gov · NCT02466204 · Registry updated: 2017-08-22

Condition / research focus: Infertility
Sponsor: Vietnam National University
Countries with listed sites: Vietnam
Registry dates and results: Start: 2015-06-01. Completion: 2017-08-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

corifollitropin alfa (drug) — also listed as: Elonva
Follitropin Beta (drug) — also listed as: Puregon

Where the study takes place — 2 listed sites

My Duc Hospital
Ho Chi Minh City, Vietnam
Site recruitment: Not reported
Research Center for Genetics and Reproductive Health
Ho Chi Minh City, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Cabergoline and Coasting to Prevent OHSS

ClinicalTrials.gov · NCT01984320 · Registry updated: 2017-08-14

Condition / research focus: OHSS
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-10. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ICSI (procedure)

Where the study takes place — 1 listed sites

IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini)
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

ClinicalTrials.gov · NCT01042704 · Registry updated: 2017-07-31

Condition / research focus: Myeloma
Sponsor: Robert Redner, MD
Countries with listed sites: United States
Registry dates and results: Start: 2008-02. Completion: 2015-03 (may be estimated). No results posted in this registry response.

Products and interventions (10)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bendamustine (drug)
Lenalidomide (drug)
Dexamethasone (drug)
Aspirin (drug)
Prophylaxis (drug)
Antibiotic (drug)
Biweekly Follow Up (other)
Cyclical Follow Up (other)
Restaging (other)
Post-Treatment Follow Up (other)

Where the study takes place — 22 listed sites

Karmanos Cancer Institute
Detroit, Michigan, United States
Site recruitment: Not reported
UPMC Cancer Centers - Teramana Cancer Center
Steubenville, Ohio, United States
Site recruitment: Not reported
UPMC Cancer Centers - Beaver
Beaver, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Jefferson
Clairton, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Arnold Palmer at Mountain View
Greensburg, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Arnold Palmer at Oakbrook
Greensburg, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Indiana
Indiana, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Johnstown
Johnstown, Pennsylvania, United States
Site recruitment: Not reported
Hematology-Oncology Associates of UPCI
McKeesport, Pennsylvania, United States
Site recruitment: Not reported
Hematology/Oncology - Private Practice
McKeesport, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Monroeville
Monroeville, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Arnold Palmer at Mt. Pleasant
Mount Pleasant, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - New Castle
New Castle, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - St. Margaret's
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Passavant
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
VA Healthcare System - 646
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Drake
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Uniontown
Uniontown, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Washington
Washington, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - North Hills
Wexford, Pennsylvania, United States
Site recruitment: Not reported
UPMC Cancer Centers - Windber
Windber, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →